Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

111.07 +0.07 (+0.06%)
Official Closing Price Updated: 7:00 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,161,078
Open 111.25
Bid (Size) 108.20 (1)
Ask (Size) 111.00 (1)
Prev. Close 111.00
Today's Range 110.11 - 111.62
52wk Range 93.25 - 130.94
Shares Outstanding 1,750,942,289
Dividend Yield 1.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
What 5 Analyst Ratings Have To Say About Abbott Laboratories
 
Via Benzinga
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc raised the price target for D.R. Horton, Inc. (NYSE: DHI) from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on... 
Via Benzinga

Performance

YTD
+1.36%
+1.36%
1 Month
+2.30%
+2.30%
3 Month
+14.59%
+14.59%
6 Month
+0.64%
+0.64%
1 Year
-7.50%
-7.50%

More News

Read More
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
Via The Motley Fool
Why Abbott Laboratories Stock Got Whacked on Wednesday
Via The Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
What's Going On With Abbott Laboratories Stock Today?
Via Benzinga
Abbott Laboratories Skids As Covid Testing Weighs On Organic Growth
Via Investor's Business Daily
A Bullish Sign Appears On Abbott Laboratories's Chart
Via Benzinga
Why Aurora Cannabis Stock Is Fading Today
Via The Motley Fool
Abbott Q4 Earnings And Revenues Top Estimates
Via Talk Markets
Microsoft's Gloomy Guidance, Boeing's Surprise Q4 Loss Pulls Market Lower
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
Via Benzinga
Earnings Outlook For Abbott Laboratories
Via Benzinga
Earnings Scheduled For January 25, 2023
Via Benzinga
Investor Optimism Declines Following Earnings Reports
Via Benzinga
Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'
Via Benzinga
Stocks Make a Quiet Move Upward Ahead of Thursday's GDP, 'Pause' Talk
Via Benzinga
Spotify To Downsize Employee Count, Activist Investor Elliott Invests Multibillion Dollars In Salesforce, Abbott Draws DOJ Investigation On Baby Formula Plant Shutdown: Today's Top Stories
Via Benzinga
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023
Via The Motley Fool
6 Dividend Growth Stocks
Via Talk Markets
Tesla, Microsoft, IBM, Intel, TI Among Companies Reporting This Week: Can Netflix's Optimism Spill Over To Rest Of Tech Space?
Via Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
Via Benzinga
ABBOTT ALERT: Bragar Eagel & Squire, P.C. is Investigating Abbott Laboratories on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
3 Top Passive-Income Stocks to Own in 2023
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.